Pharmaceutical Business review -

Pharmaceutical Business review -

Pharmaceutical Business review is using cookies

Continue Learn More

Close

November 7, 2025

Alvotech and Advanz announce MHRA marketing authorisations for Gobivaz

Alvotech and Advanz Pharma have announced the receipt of marketing authorisations from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for all four formulations of Gobivaz – Alvotech’s biosimilar to Simponi (golimumab).

The therapy is indicated for the treatment of rheumatoid arthritis and psoriatic arthritis. Credit: Towfiqu barbhuiya on Unsplash

November 4, 2025

CNX Therapeutics expands CNS portfolio with Sativex acquisition

Production & Sales

Sativex is indicated for adult patients with moderate to severe spasticity due to MS who are unresponsive to other medicines. Credit: Alexander Grey on Unsplash.

November 5, 2025

AmacaThera and Pacira sign agreement for AMT-143

Research & Development

AmacaThera's Phase I trial demonstrated that AMT-143 provided sustained release of ropivacaine for up to 14 days. Credit: AmacaThera.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

Drug Manufacturing

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Neurology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Drug Manufacturing

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Drug Manufacturing

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

PRESS RELEASES

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer at CPHI Frankfurt 2025

Packaging

Pharmaceutical Business Review

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success

LTS Wins Funding from BARDA’s Patch Forward Prize Competition for Two artnerships

Gerresheimer Delivers Solid Results in the Financial Year 2024 Despite Market Headwinds

Two Stories, One Future: Gerresheimer and Bormioli Pharma at Pharmapack 2025

Suppliers

Whitepapers

Pharmaceutical Business Review

EVERIC® Pure – The Safe Option Right from the Start

Saving Through Partnership and Innovation

Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme